Dr. Christian S Hinrichs, MD
Claim this profileRutgers Cancer Institute of New Jersey
Studies Cervical Cancer
Studies Lung Cancer
2 reported clinical trials
4 drugs studied
Area of expertise
1Cervical Cancer
Stage IV
HLA-A positive
KK-LC-1 positive
2Lung Cancer
Stage IV
KK-LC-1 positive
HLA-A positive
Affiliated Hospitals
Clinical Trials Christian S Hinrichs, MD is currently running
TCR-T Cell Therapy
for Cancer
This trial tests a new treatment using modified immune cells to target specific cancers. It focuses on patients with certain metastatic cancers that produce an abnormal protein. The treatment aims to use the body's own enhanced immune system to fight cancer.
Recruiting1 award Phase 115 criteria
E7 TCR-T Cells
for HPV-Related Cancer
The goal of this study is to determine the feasibility of administration of a single dose of E7 TCR-T cells as induction therapy prior to definitive treatment (chemoradiation or surgery) of locoregionally advanced HPV-associated cancers. The intent of E7 TCR-T cell treatment is to shrink or eliminate tumors and thereby facilitate definitive therapy and increase overall survival. This study seeks to determine 1) if E7 TCR-T cells can be administered without undue delay in definitive treatment, 2) the tumor response rate to E7 TCR-T cell treatment, and 3) the disease-free survival rate at 2 and 5 years. Participants will undergo an apheresis procedure to obtain T cells that will be genetically engineered to generate E7 TCR-T cells. They will receive a conditioning regimen, a single infusion of their own E7 TCR-T cells, and adjuvant aldesleukin. Participants will follow up to assess safety and determine tumor response and will return to their primary oncology team for definitive therapy.
Recruiting1 award Phase 1 & 2
More about Christian S Hinrichs, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christian S Hinrichs, MD has experience with
- Aldesleukin
- KK-LC-1 TCR-T Cells
- Conditioning
- E7 TCR-T Cells
Breakdown of trials Christian S Hinrichs, MD has run
Lung Cancer
Stomach Cancer
Breast Cancer
Vulvar Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christian S Hinrichs, MD specialize in?
Christian S Hinrichs, MD focuses on Cervical Cancer and Lung Cancer. In particular, much of their work with Cervical Cancer has involved Stage IV patients, or patients who are HLA-A positive.
Is Christian S Hinrichs, MD currently recruiting for clinical trials?
Yes, Christian S Hinrichs, MD is currently recruiting for 2 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Christian S Hinrichs, MD has studied deeply?
Yes, Christian S Hinrichs, MD has studied treatments such as Aldesleukin, KK-LC-1 TCR-T cells, Conditioning.
What is the best way to schedule an appointment with Christian S Hinrichs, MD?
Apply for one of the trials that Christian S Hinrichs, MD is conducting.
What is the office address of Christian S Hinrichs, MD?
The office of Christian S Hinrichs, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08901 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.